NPI: 1699946509 · LAFAYETTE, LA 70508 · Clinical Medical Laboratory · NPI assigned 03/19/2008
Authorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | WILLIAMS, KIMBERLY (VP) |
| NPI Enumeration Date | 03/19/2008 |
Other providers sharing the same authorized official: WILLIAMS, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 191,197 | $1.16M |
| 2019 | 192,263 | $1.10M |
| 2020 | 194,932 | $1.23M |
| 2021 | 421,878 | $1.70M |
| 2022 | 292,784 | $2.12M |
| 2023 | 376,402 | $2.76M |
| 2024 | 281,838 | $2.37M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 80050 | General health panel | 75,933 | 64,596 | $1.45M |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 83,138 | 68,553 | $1.16M |
| 80061 | Lipid panel | 163,424 | 132,186 | $932K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 23,617 | 20,112 | $680K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 23,600 | 20,104 | $680K |
| 80053 | Comprehensive metabolic panel | 118,126 | 97,645 | $518K |
| 83036 | Hemoglobin; glycosylated (A1C) | 116,312 | 92,086 | $466K |
| 84443 | Thyroid stimulating hormone (TSH) | 65,240 | 53,014 | $388K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 102,966 | 83,768 | $327K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 86,964 | 70,048 | $323K |
| 87536 | 6,803 | 6,120 | $312K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 21,637 | 18,184 | $293K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 13,181 | 11,236 | $265K |
| 86480 | 8,644 | 6,930 | $234K | |
| 84439 | 54,768 | 42,808 | $209K | |
| 80074 | 10,053 | 7,217 | $175K | |
| 84403 | 12,843 | 9,999 | $149K | |
| 87186 | 34,684 | 28,680 | $136K | |
| 86360 | 6,033 | 5,081 | $131K | |
| 84153 | 15,452 | 12,130 | $124K | |
| 82607 | 16,690 | 13,744 | $117K | |
| 87088 | 32,975 | 27,001 | $116K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2,985 | 2,498 | $108K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 1,583 | 1,322 | $102K |
| 84481 | 13,232 | 10,918 | $92K | |
| 82670 | 7,319 | 5,504 | $90K | |
| 86803 | 11,849 | 9,858 | $89K | |
| 82728 | 15,323 | 12,127 | $87K | |
| 87070 | 18,042 | 15,187 | $84K | |
| 85027 | 28,211 | 22,326 | $76K | |
| 82746 | 9,398 | 7,806 | $64K | |
| 86696 | 5,354 | 4,620 | $63K | |
| 81001 | 42,963 | 34,657 | $58K | |
| 84436 | 21,921 | 17,771 | $58K | |
| 83001 | 6,513 | 5,201 | $58K | |
| 84402 | 4,688 | 3,828 | $57K | |
| 84144 | 5,755 | 4,390 | $57K | |
| 83550 | 15,523 | 12,410 | $56K | |
| 87081 | 14,700 | 12,402 | $55K | |
| 86592 | 26,139 | 20,317 | $53K | |
| 87077 | 13,382 | 11,071 | $50K | |
| 84702 | 8,843 | 5,370 | $50K | |
| 86376 | 6,250 | 5,348 | $48K | |
| 83970 | 3,192 | 2,721 | $47K | |
| 86038 | 7,593 | 6,474 | $47K | |
| 83540 | 19,005 | 15,044 | $46K | |
| 83002 | 4,893 | 3,861 | $44K | |
| 82550 | 15,173 | 12,256 | $44K | |
| 87522 | Neg quan hep c or qual rna | 1,801 | 1,579 | $43K |
| 82043 | 16,617 | 13,856 | $41K | |
| 84146 | 4,705 | 3,670 | $41K | |
| 86695 | 5,266 | 4,547 | $40K | |
| 86780 | 5,397 | 4,585 | $38K | |
| 84550 | 22,696 | 18,372 | $38K | |
| 82570 | 16,405 | 13,600 | $34K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 10,574 | 8,730 | $34K |
| 82672 | 2,441 | 2,150 | $31K | |
| 86003 | 696 | 517 | $30K | |
| 84479 | 11,344 | 9,193 | $28K | |
| 83615 | 15,206 | 12,064 | $28K | |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 54 | 53 | $27K |
| 82565 | 16,252 | 12,613 | $26K | |
| 84480 | 4,907 | 3,967 | $26K | |
| 84100 | 17,145 | 13,488 | $26K | |
| 82784 | 2,072 | 1,808 | $26K | |
| 87340 | 4,748 | 3,851 | $25K | |
| 84450 | 14,945 | 11,564 | $25K | |
| 82248 | 16,430 | 13,166 | $25K | |
| 86140 | 10,710 | 8,602 | $24K | |
| 83655 | 3,071 | 2,776 | $23K | |
| 82310 | 13,639 | 10,556 | $23K | |
| 86769 | 623 | 427 | $22K | |
| 83735 | 8,864 | 7,052 | $22K | |
| 84075 | 13,269 | 10,286 | $22K | |
| 87901 | 152 | 141 | $21K | |
| 82947 | 16,194 | 12,606 | $20K | |
| 86235 | 506 | 391 | $20K | |
| 84520 | 15,863 | 12,275 | $20K | |
| 82040 | 13,317 | 10,303 | $20K | |
| 84295 | 13,356 | 10,315 | $20K | |
| 80081 | 507 | 428 | $19K | |
| 86431 | 6,794 | 5,800 | $19K | |
| 84132 | 13,176 | 10,320 | $19K | |
| 80164 | 4,433 | 3,323 | $19K | |
| 82435 | 13,412 | 10,367 | $19K | |
| 82247 | 13,881 | 10,638 | $18K | |
| 87075 | 3,959 | 3,303 | $18K | |
| 87900 | 251 | 220 | $17K | |
| 82950 | 8,235 | 6,048 | $17K | |
| 80076 | 4,560 | 3,598 | $15K | |
| 83880 | 1,027 | 916 | $15K | |
| 82785 | 1,671 | 1,458 | $15K | |
| 82627 | 1,333 | 1,062 | $15K | |
| 84155 | 13,160 | 10,180 | $15K | |
| 85652 | 11,620 | 9,301 | $14K | |
| 82533 | 1,834 | 1,477 | $14K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 717 | 636 | $13K |
| 86361 | 1,062 | 902 | $13K | |
| 86677 | 1,048 | 858 | $13K | |
| 87427 | 2,080 | 1,725 | $12K | |
| 81003 | 11,173 | 9,180 | $12K | |
| 86706 | 2,045 | 1,727 | $12K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 254 | 211 | $11K |
| 83690 | 3,263 | 2,675 | $11K | |
| 87209 | 1,267 | 1,024 | $11K | |
| 83525 | 1,804 | 1,487 | $11K | |
| 82150 | 3,152 | 2,570 | $10K | |
| 87906 | 140 | 129 | $10K | |
| 86060 | 2,819 | 2,407 | $10K | |
| 85610 | 7,423 | 6,110 | $10K | |
| 82787 | 680 | 604 | $10K | |
| 82951 | 1,799 | 1,317 | $10K | |
| 87046 | 2,089 | 1,732 | $10K | |
| 87045 | 2,077 | 1,726 | $10K | |
| 86800 | 949 | 839 | $8K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 130 | 105 | $8K |
| 84305 | 696 | 603 | $8K | |
| 82652 | 891 | 627 | $7K | |
| 84156 | 5,648 | 4,496 | $7K | |
| 82977 | 3,048 | 2,300 | $7K | |
| 83498 | 540 | 463 | $7K | |
| 86850 | 1,465 | 1,216 | $7K | |
| 86593 | 3,050 | 2,542 | $7K | |
| 86225 | 1,008 | 848 | $7K | |
| 86787 | 929 | 783 | $7K | |
| 83721 | 1,816 | 1,523 | $6K | |
| 85730 | 3,509 | 2,659 | $6K | |
| 84460 | 4,113 | 3,115 | $6K | |
| 80177 | 1,011 | 891 | $5K | |
| 80051 | 2,418 | 1,935 | $5K | |
| 87177 | 1,269 | 1,027 | $5K | |
| 86708 | 819 | 685 | $5K | |
| 86200 | 751 | 619 | $5K | |
| 86762 | 616 | 539 | $5K | |
| 85045 | 2,276 | 1,890 | $5K | |
| 82140 | 685 | 536 | $4K | |
| 36415 | Collection of venous blood by venipuncture | 24,522 | 21,989 | $4K |
| 80178 | 1,541 | 1,222 | $3K | |
| 86702 | 548 | 448 | $3K | |
| 84154 | 337 | 299 | $3K | |
| 84703 | 847 | 642 | $3K | |
| 86160 | 465 | 364 | $3K | |
| 82952 | 1,742 | 1,272 | $3K | |
| 87902 | 19 | 12 | $3K | |
| 82575 | 528 | 412 | $2K | |
| 87324 | 434 | 358 | $2K | |
| 84681 | 189 | 180 | $2K | |
| 82274 | 241 | 208 | $2K | |
| 86665 | 122 | 100 | $2K | |
| 80185 | 465 | 363 | $2K | |
| 80069 | 824 | 614 | $2K | |
| 86900 | 1,177 | 978 | $2K | |
| 86901 | 1,155 | 953 | $2K | |
| 80197 | 420 | 282 | $2K | |
| 86364 | 256 | 248 | $2K | |
| 87205 | 1,027 | 808 | $2K | |
| 86704 | 203 | 181 | $1K | |
| 85060 | 626 | 499 | $1K | |
| 87350 | 195 | 166 | $1K | |
| 86701 | 285 | 241 | $1K | |
| 86777 | 160 | 137 | $1K | |
| 84134 | 328 | 272 | $1K | |
| 87329 | 213 | 166 | $1K | |
| 83020 | 167 | 150 | $1K | |
| 86709 | 193 | 143 | $1K | |
| 85660 | 384 | 289 | $991.95 | |
| 86644 | 130 | 110 | $970.47 | |
| 86664 | 113 | 92 | $932.22 | |
| 82374 | 748 | 503 | $863.14 | |
| 82024 | 46 | 37 | $824.26 | |
| 87210 | 363 | 339 | $798.22 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 16 | 12 | $622.50 |
| 89055 | 299 | 242 | $607.71 | |
| 86765 | 90 | 85 | $572.46 | |
| 87535 | 26 | 26 | $565.21 | |
| 86304 | 97 | 58 | $523.42 | |
| 83520 | 79 | 56 | $472.64 | |
| 84466 | 86 | 73 | $460.89 | |
| 87076 | 90 | 84 | $448.89 | |
| 86141 | 59 | 54 | $378.57 | |
| 87521 | Neg quan hep c or qual rna | 29 | 14 | $365.06 |
| 86308 | 134 | 111 | $355.40 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 22 | 22 | $351.81 |
| 83021 | 27 | 26 | $335.90 | |
| 84425 | 24 | 24 | $304.19 | |
| 87040 | 47 | 44 | $285.95 | |
| 85018 | 260 | 204 | $258.64 | |
| 82378 | 27 | 22 | $249.70 | |
| 83704 | 14 | 14 | $230.29 | |
| 86341 | 16 | 16 | $199.22 | |
| 83516 | 16 | 12 | $180.29 | |
| 84270 | 13 | 12 | $176.59 | |
| 86738 | 19 | 17 | $163.59 | |
| 80183 | 27 | 27 | $143.75 | |
| 86663 | 14 | 12 | $120.33 | |
| 85014 | 124 | 92 | $119.17 | |
| 81025 | 32 | 25 | $107.82 | |
| 80184 | 27 | 24 | $107.64 | |
| 84478 | 63 | 42 | $92.36 | |
| 80299 | 14 | 12 | $90.11 | |
| 84165 | 31 | 27 | $88.71 | |
| 82105 | 17 | 13 | $74.28 | |
| 80156 | 42 | 25 | $57.60 | |
| 82465 | 56 | 39 | $56.93 | |
| 85007 | 30 | 29 | $33.53 | |
| 36416 | 187 | 103 | $3.75 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 2,903 | 2,677 | $0.00 |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 509 | 459 | $0.00 |
| S3600 | Stat laboratory request (situations other than s3601) | 156 | 110 | $0.00 |